U.S. Vaccines Market to 2032
Overview
The U.S. Vaccines Market is expected to reach a 31,891.84 USD Billion by 2032 and is projected to grow at a CAGR of 10.77% from 2025 to 2032.
Revenue, 2024 (USD Billion)
18,186.96
Forecast, 2032 (USD Billion)
31,891.84
CAGR, 2024 - 2032
10.77%
Report Coverage
U.S.
U.S. Vaccines Market 2018-2032 USD Billion
U.S. Vaccines Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 18,186.96 USD Billion
- Projected Market Size (2032): 31,891.84 USD Billion
- CAGR (2025-2032): 10.77%
Key Findings of U.S. Vaccines Market
- The U.S. Vaccines Market was valued at 18,186.96 USD Billion in 2024.
- The U.S. Vaccines Market is likely to grow at a CAGR of 10.77% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 15,224.74 USD Billion
- The fastest growing segment Influenza in Diseases Segment grew Fastest with a CAGR of 12.64% during the forecast period from 2024 to 2032.
U.S. Vaccines Market Scope
U.S. Vaccines Market Segmentation & Scope
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Route of Administration
- Nasal
- Oral
- Injectable
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
U.S. Vaccines Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 18,186.96 USD Billion |
| Market Value in 2032 | 31,891.84 USD Billion |
| CAGR (2025-2032) | 10.77% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Composition,Kind,Diseases,Route of Administration,Age of Administration,Distribution Channel,End User |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 18,186.96 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 18,186.96 USD Billion in 2024.
Segments and Scope
-
U.S. Vaccines Market to 2032, By Type
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the largest segment in U.S. Vaccines Market to 2032 with a revenue of 6,959.77 USD Billion in the year 2024.
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the Fastest growing segment in U.S. Vaccines Market to 2032 with a Growth rate of 11.50 % in forecast period 2025-2032.
-
U.S. Vaccines Market to 2032, By Composition
- Combination Vaccines is the largest segment in U.S. Vaccines Market to 2032 with a revenue of 13,623.02 USD Billion in the year 2024.
- Combination Vaccines is the Fastest growing segment in U.S. Vaccines Market to 2032 with a Growth rate of 11.03 % in forecast period 2025-2032.
-
U.S. Vaccines Market to 2032, By Kind
- Routine Vaccine is the largest segment in U.S. Vaccines Market to 2032 with a revenue of 11,207.15 USD Billion in the year 2024.
- Recommended Vaccines is the Fastest growing segment in U.S. Vaccines Market to 2032 with a Growth rate of 10.17 % in forecast period 2025-2032.
-
U.S. Vaccines Market to 2032, By Diseases
- Pneumoccocal Disease is the largest segment in U.S. Vaccines Market to 2032 with a revenue of 2,696.60 USD Billion in the year 2024.
- Influenza is the Fastest growing segment in U.S. Vaccines Market to 2032 with a Growth rate of 12.12 % in forecast period 2025-2032.
-
U.S. Vaccines Market to 2032, By Route of Administration
- Injectable is the largest segment in U.S. Vaccines Market to 2032 with a revenue of 15,224.74 USD Billion in the year 2024.
- Injectable is the Fastest growing segment in U.S. Vaccines Market to 2032 with a Growth rate of 10.96 % in forecast period 2025-2032.
-
U.S. Vaccines Market to 2032, By Age of Administration
- Pediatric Vaccines is the largest segment in U.S. Vaccines Market to 2032 with a revenue of 10,017.31 USD Billion in the year 2024.
- Adult Vaccines is the Fastest growing segment in U.S. Vaccines Market to 2032 with a Growth rate of 10.30 % in forecast period 2025-2032.
-
U.S. Vaccines Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in U.S. Vaccines Market to 2032 with a revenue of 10,534.16 USD Billion in the year 2024.
- Retail Pharmacy is the Fastest growing segment in U.S. Vaccines Market to 2032 with a Growth rate of 9.80 % in forecast period 2025-2032.
-
U.S. Vaccines Market to 2032, By End User
- Community Hospitals is the largest segment in U.S. Vaccines Market to 2032 with a revenue of 9,202.32 USD Billion in the year 2024.
- Specialty Centres is the Fastest growing segment in U.S. Vaccines Market to 2032 with a Growth rate of 10.26 % in forecast period 2025-2032.
U.S. Vaccines Market Company Share Analysis
U.S. Vaccines Market Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Vaccines Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Vaccines Market is segmented based on Segmentation Type,Composition,Kind,Diseases,Route of Administration,Age of Administration,Distribution Channel,End User.
U.S. Vaccines Market was valued at USD 18,186.96(Revenue in USD Billion) in 2020.
U.S. Vaccines Market is projected to grow at a CAGR of 10.77% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the U.S. Vaccines Market, holding a largest market share of 15,224.74 USD Billion in 2024
Coming Soon....
U.S. Vaccines Market Scope
U.S. Vaccines Market Segmentation & Scope
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Route of Administration
- Nasal
- Oral
- Injectable
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Frequently Asked Questions
The U.S. Vaccines Market is segmented based on Segmentation Type,Composition,Kind,Diseases,Route of Administration,Age of Administration,Distribution Channel,End User.
U.S. Vaccines Market was valued at USD 18,186.96(Revenue in USD Billion) in 2020.
U.S. Vaccines Market is projected to grow at a CAGR of 10.77% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Vaccines Market for final year is USD 31,891.84 (USD Billion).
U.S. Vaccines Market Company Profiling
Frequently Asked Questions
The U.S. Vaccines Market is segmented based on Segmentation Type,Composition,Kind,Diseases,Route of Administration,Age of Administration,Distribution Channel,End User.
U.S. Vaccines Market was valued at USD 18,186.96(Revenue in USD Billion) in 2020.
U.S. Vaccines Market is projected to grow at a CAGR of 10.77% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Vaccines Market for final year is USD 31,891.84 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.